Concerto HealthAI and Pfizer to Develop New Study Designs Using Real-world Evidence and AI for Various Cancers

Concerto HealthAI (MA, USA) and Pfizer (NY, USA) have announced the expansion of their existing collaboration, with the aim of developing new study designs for various cancers by employing real-world evidence and artificial intelligence (AI).

New call-to-action